Novoheart Holdings Inc. announced that Iris Lo has tendered her resignation as Chief Financial Officer and Corporate Secretary of the Company effective January 4, 2019. Camie Chan, Chief Operating Officer, will simultaneously serve as the Interim Chief Financial Officer and Corporate Secretary during the transition.
Novoheart Holdings Inc.
Equities
NVH
CA67011V1076
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+8.90% | 105B | |
-0.61% | 104B | |
+5.09% | 22.94B | |
-10.38% | 22.34B | |
-6.54% | 19.25B | |
-39.98% | 17.08B | |
-9.43% | 16.96B | |
+8.45% | 14.16B | |
+37.95% | 12.63B |